›› 2009, Vol. 29 ›› Issue (12): 1434-.

• 论著(基础研究) • 上一篇    下一篇

不同血液透析液对U937细胞凋亡和PKCδ表达的影响

朱小娟1, 郭黎莉2, 潘 瑜1, 谭龙益3, 张必嘏2, 金 燕2, 黄明珠2, 张国兰2, 蒙海燕2, 薄卫亚2, 徐琴君2, 金惠敏1   

  1. 上海交通大学 1. 医学院第三人民医院肾脏内科, 上海 201900;2. 第一人民医院宝山分院血液透析室, 上海 200940;3. 第一人民医院宝山分院检验科, 上海 200940
  • 出版日期:2009-12-25 发布日期:2009-12-25
  • 通讯作者: 郭黎莉, 电子信箱: gflmei@sohu.com。
  • 作者简介:朱小娟(1982—), 女, 硕士生;电子信箱: zhuxiaojuan200709@126.com。
  • 基金资助:

    上海市卫生局基金(2007129)和上海市宝山区科委基金(08-E-28)

Effects of different dialysates on apoptosis and expression of PKCdelta of U937 cell line

ZHU Xiao-juan1, GUO Li-li2, PAN Yu1, TAN Long-yi2, ZHANG Bi-gu2, JIN Yan2, HUANG Ming-zhu2, ZHANG Guo-lan2, MENG Hai-yan2, BO Wei-ya2, XU Qin-jun2, JIN Hui-min1   

  1. 1. Department of Nephrology, The Third People's Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai 201900, China;2. Hemodialysis Unit, 3. Clinical Laboratory, Baoshan Branch, The First People's Hospital, Shanghai Jiaotong University, Shanghai 200940, China
  • Online:2009-12-25 Published:2009-12-25
  • Supported by:

    Shanghai Municipal Health Bureau Foundation, 2007129; Foundation from Science and Technology Committee of Baoshan District, Shanghai, 08-E-28

摘要:

目的 研究不同血液透析液对U937细胞蛋白激酶C-δ(PKCδ)表达及细胞凋亡的影响。方法 在对数生长期人单核细胞株U937细胞培养液中添加不同血液透析液进行干预,分为A液+B液组(血液透析液A液+B液组合)、A液+B液+PKCδ特异性抑制剂(rottlerin)组、A液+B粉组(血液透析液A液+B粉组合)、A液+B粉+ rottlerin组,同时设立空白对照和正常对照组。分组干预后24 h和48 h分别收集细胞,Hoechst33258染色后荧光显微镜观察细胞形态学改变;Annexin V-FITC/PI双标记流式细胞术检测细胞凋亡;RT-PCR和Western blotting 检测PKCδ mRNA和蛋白表达。结果 A液+B粉组凋亡细胞明显增多,呈凋亡典型形态学改变,分组干预24 h和48 h的细胞凋亡率分别为(34.99±3.54)%和(46.35±4.22)%,明显高于相应时间点空白对照组的(7.40±1.33)%和(7.62±0.95)%、正常对照组的(5.37±0.29)%和(6.46±1.02)%和A液+B粉+rottlerin组的(23.58±4.12)%和(33.70±4.50)%(P<0.05);同时与两对照组和A液+B粉+rottlerin组比较,A液+B粉组U937细胞PKCδ mRNA和蛋白表达均明显上调(P<0.05)。A液+B液组细胞凋亡率及PKCδ mRNA和蛋白表达与两对照组和A液+B液+rottlerin组比较,差异均无统计学意义(P>0.05)。结论 血液透析液A液+B粉组合对U937细胞有明显促凋亡作用,其机制可能与上调细胞PKCδ表达有关;与A液+B粉组合比较,选择A液+B液组合作为血液透析液可降低患者外周血单核细胞的细胞凋亡率。

关键词: 透析液, U937细胞, 细胞凋亡, 蛋白激酶C-δ

Abstract:

Objective To investigate the effects of different dialysates on expression of protein kinase C-δ (PKCδ) and apoptosis of U937 cell line. Methods Different dialysates were added into culture fluid with U937 cell line at exponential phase of growth, and groups were divided: fluid A+fluid B group (dialysate A+dialysate B), fluid A+fluid B+rottlerin (PKCδ specific inhibitor)group, fluid A+powder B group (dialysate A+powder B) and fluid A+powder B + rottlerin group. Besides, blank control group and normal control group were established. Cells were harvested 24 h and 48 h after treatment, morphological changes were observed by Hoechst33258 fluorescence staining, cell apoptosis was measured by Annexin-V-FITC/PI double staining, and expression of PKCδ mRNA and protein was detected by RT-PCR and Western blotting, respectively. Results Cell apoptosis significantly increased in fluid A+powder B group, with typical morphology of apoptosis. After treatment for 24 h and 48 h, cell apoptosis rates in fluid A+powder B group were (34.99±3.54)% and (46.35±4.22)%, respectively, significantly higher than those at corresponding time points in blank control group [(7.40±1.33)% and (7.62±0.95)%], normal control group [(5.37±0.29)% and (6.46±1.02)%] and fluid A+powder B+rottlerin group [(23.58±4.12)% and (33.70±4.50)%] (P<0.05). Compared with normal control group, blank control group and fluid A+powder B+rottlerin group, the expression of PKCδ mRNA and protein of U937 cells in fluid A+powder B group were significantly increased (P<0.05). There was no significant difference in cell apoptosis rates and expression of PKCδ mRNA and protein between fluid A+fluid B group and blank control group, normal control group and fluid A+fluid B+rottlerin group (P>0.05). Conclusion Fluid A+powder B can significantly increase apoptosis of U937 cell line, the mechanism of which may be associated with the up-regulation of expression of PKCδ. Compared with fluid A+powder B, fluid A+fluid B is superior in reducing  apoptosis of peripheral blood monouclear cells.

Key words: dialysate, U937 cell, cell apoptosis, protein kinase C-δ